ADAPTIVE BIOTECHNOLOGIES ANNOUNCES CLINICAL LAB FEE SCHEDULE RATE OF $2,007 FOR CLONOSEQ® TEST FOR MINIMAL RESIDUAL DISEASE ASSESSMENT IS EFFECTIVE AS OF JANUARY 1ST, 2025

Reuters · 01/07 12:30

Please log in to view news